Cambria, Elena http://orcid.org/0000-0001-6896-5421
Coughlin, Mark F.
Floryan, Marie A.
Offeddu, Giovanni S.
Shelton, Sarah E. http://orcid.org/0000-0002-9358-058X
Kamm, Roger D. http://orcid.org/0000-0002-7232-304X
Article History
Accepted: 7 December 2023
First Online: 18 January 2024
Competing interests
: R.D.K. is a co-founder of AIM Biotech, a company that markets microfluidic technologies and receives research support from Amgen, AbbVie, Boehringer-Ingelheim, GSK, Novartis, Roche, Takeda, Eisai, EMD Serono and Visterra. None of these activities is related to the content of this article. The other authors declare no competing interests.